These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 8873690)

  • 1. Dose-ranging evaluation of bumetanide pharmacodynamics in critically ill infants.
    Sullivan JE; Witte MK; Yamashita TS; Myers CM; Blumer JL
    Clin Pharmacol Ther; 1996 Oct; 60(4):424-34. PubMed ID: 8873690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of bumetanide in critically ill infants.
    Sullivan JE; Witte MK; Yamashita TS; Myers CM; Blumer JL
    Clin Pharmacol Ther; 1996 Oct; 60(4):405-13. PubMed ID: 8873688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the variability in the pharmacokinetics and pharmacodynamics of bumetanide in critically ill infants.
    Sullivan JE; Witte MK; Yamashita TS; Myers CM; Blumer JL
    Clin Pharmacol Ther; 1996 Oct; 60(4):414-23. PubMed ID: 8873689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bumetanide continuous infusions in critically ill pediatric patients.
    McCallister KM; Chhim RF; Briceno-Medina M; Shelton CM; Figueroa M; Rayburn M
    Pediatr Crit Care Med; 2015 Feb; 16(2):e19-22. PubMed ID: 25560424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of probenecid on the dose-response relationship of bumetanide at steady state.
    Lau HS; Shih LJ; Smith DE
    J Pharmacol Exp Ther; 1983 Oct; 227(1):51-4. PubMed ID: 6620171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of duration of diuretic effect in preventing sodium retention.
    Ferguson JA; Sundblad KJ; Becker PK; Gorski JC; Rudy DW; Brater DC
    Clin Pharmacol Ther; 1997 Aug; 62(2):203-8. PubMed ID: 9284857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and pharmacodynamics of the diuretic bumetanide in the elderly.
    Oberbauer R; Krivanek P; Turnheim K
    Clin Pharmacol Ther; 1995 Jan; 57(1):42-51. PubMed ID: 7828380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frusemide administration in critically ill patients by continuous compared to bolus therapy.
    Ostermann M; Alvarez G; Sharpe MD; Martin CM
    Nephron Clin Pract; 2007; 107(2):c70-6. PubMed ID: 17890871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-dependent evaluation of the effects of nebulized furosemide on pulmonary function in ventilated preterm infants.
    Prabhu VG; Keszler M; Dhanireddy R
    J Perinatol; 1998; 18(5):357-60. PubMed ID: 9766411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative diuretic and tissue distribution study of bumetanide and furosemide in the dog.
    Cohen MR; Hinsch E; Vergona R; Ryan J; Kolis SJ; Schwartz MA
    J Pharmacol Exp Ther; 1976 Jun; 197(3):697-702. PubMed ID: 932999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmacokinetics of bumetanide in the newborn infant.
    Lopez-Samblas AM; Adams JA; Goldberg RN; Modi MW
    Biol Neonate; 1997; 72(5):265-72. PubMed ID: 9395836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and pharmacodynamics of bumetanide in critically ill pediatric patients.
    Marshall JD; Wells TG; Letzig L; Kearns GL
    J Clin Pharmacol; 1998 Nov; 38(11):994-1002. PubMed ID: 9824779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of furosemide regimens in neonates treated with extracorporeal membrane oxygenation.
    van der Vorst MM; Wildschut E; Houmes RJ; Gischler SJ; Kist-van Holthe JE; Burggraaf J; van der Heijden AJ; Tibboel D
    Crit Care; 2006; 10(6):R168. PubMed ID: 17140428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bumetanide and furosemide.
    Brater DC; Chennavasin P; Day B; Burdette A; Anderson S
    Clin Pharmacol Ther; 1983 Aug; 34(2):207-13. PubMed ID: 6872415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
    Licata G; Di Pasquale P; Parrinello G; Cardinale A; Scandurra A; Follone G; Argano C; Tuttolomondo A; Paterna S
    Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An evaluation of off-label fenoldopam use in the neonatal intensive care unit.
    Yoder SE; Yoder BA
    Am J Perinatol; 2009 Nov; 26(10):745-50. PubMed ID: 19452425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gender effect on diuretic response to hydrochlorothiazide and furosemide.
    Franson KL; Kuk JM; Lam NP; Lau AH
    Int J Clin Pharmacol Ther; 1996 Mar; 34(3):101-5. PubMed ID: 8705087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study of the pharmacodynamic differences between immediate and extended release bumetanide formulations.
    Hamed E; Gerson MC; Millard RW; Sakr A
    Int J Pharm; 2003 Nov; 267(1-2):129-40. PubMed ID: 14602391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of bumetanide for oliguric acute renal failure in preterm infants.
    Oliveros M; Pham JT; John E; Resheidat A; Bhat R
    Pediatr Crit Care Med; 2011 Mar; 12(2):210-4. PubMed ID: 20625335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and pharmacodynamics of intravenous bumetanide in mutant Nagase analbuminemic rats: importance of globulin binding for the pharmacodynamic effects.
    Kim EJ; Lee MG
    Biopharm Drug Dispos; 2001 May; 22(4):147-56. PubMed ID: 11745917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.